publication . Article . 2015

Las dietas hipersaturadas que contienen surimi de calamar enriquecido con glucomanano y glucomanano/espirulina afectan a la glucemia y a los niveles plasmáticos y adiposos de leptina y adiponectina en ratas fa/fa en crecimiento

Vázquez-Velasco, Miguel; González-Torres, Laura; Méndez, María Teresa; Bastida, Sara; Benedí, Juana; González-Muñoz, M. José; Sánchez-Muniz, Francisco J.;
Open Access English
  • Published: 01 Dec 2015
  • Publisher: Grupo Arán
Type 2 diabetes is a very prevalent chronic disease. Among dietary factors for its prevention and treatment, interest has grown in satiating fibre (konjac glucomannan) and spirulina. Our previous studies suggest that glucomannan itself and/or in conjunction to spirulina displayed hypolipemic and antioxidant effects when incorporated to squid surimi as functional ingredients. The present study aims to determine whether glucomannan- enriched or glucomannan plus spirulina-enriched squid-surimi improve plasma glucose and insulin levels in Zucker fa/fa rats fed a high saturated fat diet. Twenty four growing rats, divided into three groups, were given modified AIN-93M...
free text keywords: Functional foods, Glucomannan, Obesity, Spirulina, Type 2 diabetes mellitus, Alimentos funcionales, Diabetes mellitus tipo 2, Espirulina, Glucomanano, Obesidad
41 references, page 1 of 3

1. Llopiz PQ, García-Galbis MR. Control glicémico a través del ejercicio en pacientes con diabetes mellitus tipo 2: Revisión sistemática. Nutr Hosp 2015; 31: 1465-1472.

2. Zhang P, Zhang X, Brown J, Vistisen D, Sicree R, Shaw J, Nichols G. Global healthcare expenditure on diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010; 87: 293-301.

3. Winett RA, Davy BM, Marinik E, Savla J, Winett SG, Phillips SM, Lutes LD. Developing a new treatment paradigm for disease prevention and healthy aging. Transl Behav Med 2014; 4: 117-123.

4. Hirahatake KM, Slavin JL, Maki KC, Adams SH. Associations between dairy foods, diabetes, and metabolic health: potential mechanisms and future directions. Metabolism 2014; 63: 618-627. [OpenAIRE]

5. Cho SS, Qi L, Fahey GC, Klurfeld DM. Consumption of cereal fiber, mixtures of whole grains and bran, and whole grains and risk reduction in type 2 diabetes, obesity, and cardiovascular disease. Am J Clin Nutr 2013; 98: 594-619.

6. Borderías AJ, Sánchez-Alonso I, Pérez-Mateos M. New applications of fibres in foods: addition to fishery products. Trends Food Sci Tech 2005; 16: 458-465.

7. Moreno H, Herranz B, Pérez-Mateos M, Isabel Sánchez-Alonso, Borderías AJ. New Alternatives in Seafood Restructured Products. Crit Rev Food Sci Nutr 2014. DOI: 10.1080/10408398.2012.719942.

8. Gonzalez-Canga A, Fernandez-Martinez N, Sahagun AM, Garcia-Vieitez JJ, Diez-Liebana MJ, Calle-Pardo AP, Castro-Robles LJ, Sierra-Vega M. Glucomanano: propiedades y aplicaciones terapéuticas. Nutr Hosp 2004; 19: 45-50. [OpenAIRE]

9. Vázquez-Velasco M, González-Torres L, Olivero-David R, Bastida S, Benedí J, Sánchez-Reus M, González-Muñoz M, Sánchez-Muniz FJ. Lipoproteinemia and arylesterase activity in Zucker Fa/Fa rats fed glucomannan/spirulina-enriched squid-surimi. Eur J Lipid Sci Tech 2013; 115: 1274-1283.

10. Vazquez-Velasco M, Gonzalez-Torres L, Lopez-Gasco P, Bastida S, Benedi J, Sanchez-Reus MI, Gonzalez-Munoz MJ, Sanchez-Muniz FJ. Liver oxidation and inflammation in Fa/ Fa rats fed glucomannan/spirulina-surimi. Food Chem 2014; 159: 215-221.

11. Vázquez-Velasco M, González-Torres L, López-Gasco P, Bastida S, Benedí J, González-Muñoz MJ, Sánchez-Muniz FJ. Effects of glucomannan/spirulina-surimi on liver oxidation and inflammation in Zucker rats fed atherogenic diets. J Phys Biochem 2015. DOI 10.1007/s13105-015-0425-9

12. Vuksan V, Jenkins DJ, Spadafora P, Sievenpiper JL, Owen R, Vidgen E, Brighenti F, Josse R, Leiter LA, Bruce-Thompson C. Konjac-mannan (glucomannan) improves glycemia and other associated risk factors for coronary heart disease in type 2 diabetes. A randomized controlled metabolic trial. Diabetes Care 1999; 22: 913-919.

13. Nagaoka S, Shimizu K, Kaneko H, Shibayama F, Morikawa K, Kanamaru Y, Otsuka A, Hirahashi T, Kato T. A novel protein C-phycocyanin plays a crucial role in the hypocholesterolemic action of Spirulina platensis concentrate in rats. J Nutr 2005; 135: 2425-2430.

14. Joventino IP, Alves HG, Neves LC, Pinheiro-Joventino F, Leal LK, Neves SA, Ferreira FV, Brito GA, Viana GB. The microalga Spirulina platensis presents anti-inflammatory action as well as hypoglycemic and hypolipidemic properties in diabetic rats. J Complement Integr Med 2012; 9: 1553-3840.

15. Ou Y, Lin L, Yang X, Pan Q, Cheng X. Antidiabetic potential of phycocyanin: effects on KKAy mice. Pharm Biol 2013; 51: 539-544.

41 references, page 1 of 3
Powered by OpenAIRE Open Research Graph
Any information missing or wrong?Report an Issue